Hamilton and MLL Munich Leukemia Laboratory announce a new collaboration agreement in molecular diagnostic automation

Bonaduz, Switzerland, and Munich, Germany (May 30, 2018) – Hamilton Bonaduz AG and MLL - Munich Leukemia Laboratory signed a collaboration agreement to develop automation of the NGS workflow. The collaboration includes a non-exclusive exchange of expertise and business. The Microlab® STAR™ automated workstation is the platform chosen for the automation of the NGS library preparation workflow.

This collaboration has already produced an Application Note wherein is described a validated method for fully automated TruSeq® DNA PCR-Free library preparation and TruSeq® Stranded Total RNA library preparation with reliable yield and quality. This validated method qualifies for inclusion into an accredited diagnostic process, in accordance with DIN EN ISO 15189.

“Hamilton’s automated technologies have a proven track record of success”, said Torsten Haferlach, Chief Executive Officer and Co-Founder of MLL; “their platform-agnostic approach to molecular diagnostics aligns perfectly with MLL’s mission to automate, standardize, and create flexible library preparation NGS workflows”.

“MLL is a very well-known laboratory and excellent in the field of leukemia research and diagnosis”, said Guido Meneghini, Senior Director of International Sales at Hamilton Bonaduz AG. “Their technology expertise and innovative spirit, together with the highest level of analytical instrumentation, provide Hamilton the opportunity to expand and innovate in NGS, applied to molecular diagnostics”.

Download Application Note

About MLL - Munich Leukemia Laboratory

The MLL - Munich Leukemia Laboratory was founded in 2005 to take diagnostic responsibility for patients with leukemia and lymphoma for both in-patient and out-patient settings. The team of 190 hematologists, researchers and technicians works to optimize and refine diagnostics, including automation of laboratory procedures and improvements according to the established norms of EN ISO 15189 as well as national and international involvement in scientific projects and research trials. MLL is committed to expanding and improving high-quality diagnostics of hematological neoplasms, at the highest scientific and technical levels, investigating > 80,000 samples per year.

About Hamilton Robotics

A pioneer in liquid handling equipment and laboratory automation technology, Hamilton Robotics is renowned for advancing life science and biotechnology industries through reliability, performance, and flexibility. Hamilton is the industry leader in design, and manufacturing with patented technologies such as Compression-induced O-Ring Expansion (CO-RE), Total Aspiration and Dispensing Monitoring (TADM), and Anti-Droplet Control (ADC). Hamilton’s platforms include Hamilton VANTAGE, its newest vertically integrated liquid handler, Microlab STAR, Hamilton’s best-selling automated pipetting platform, and Microlab NIMBUS, the first in its class of compact, high-speed, personalized pipetting workstations.